171 related articles for article (PubMed ID: 17617030)
1. Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: evidence for gender interaction among Brazilians.
Rios DL; D'Onofrio LO; Cerqueira CC; Bonfim-Silva R; Carvalho HG; Santos-Filho A; Galvão-Castro B
Clin Chem Lab Med; 2007; 45(7):874-8. PubMed ID: 17617030
[TBL] [Abstract][Full Text] [Related]
2. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
[TBL] [Abstract][Full Text] [Related]
3. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
5. A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease.
Kaman D; Ilhan N; Metin K; Akbulut M; Ustündağ B
Cell Biochem Funct; 2009 Mar; 27(2):88-92. PubMed ID: 19226538
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease.
Balcerzyk A; Zak I; Krauze J
Arch Med Res; 2007 Jul; 38(5):545-50. PubMed ID: 17560461
[TBL] [Abstract][Full Text] [Related]
7. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
[TBL] [Abstract][Full Text] [Related]
8. Human paraoxonase gene polymorphisms and coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA
Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995
[TBL] [Abstract][Full Text] [Related]
9. The risk of coronary artery disease in population of Taiwan is associated with Cys-Ser 311 polymorphism of human paraoxonase (PON)-2 gene.
Pan JP; Lai ST; Chiang SC; Chou SC; Chiang AN
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):415-21. PubMed ID: 12433026
[TBL] [Abstract][Full Text] [Related]
10. The role of polymorphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovascular risk: a pilot study.
Gluba A; Pietrucha T; Banach M; Piotrowski G; Rysz J
Angiology; 2010 Feb; 61(2):157-65. PubMed ID: 19939821
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
[TBL] [Abstract][Full Text] [Related]
12. Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.
Birjmohun RS; Vergeer M; Stroes ES; Sandhu MS; Ricketts SL; Tanck MW; Wareham NJ; Jukema JW; Kastelein JJ; Khaw KT; Boekholdt SM
PLoS One; 2009 Aug; 4(8):e6809. PubMed ID: 19710913
[TBL] [Abstract][Full Text] [Related]
13. PON1 L55M and Q192R gene polymorphisms and CAD risks in patients with hyperlipidemia : Clinical study of possible associations.
Chen H; Ding S; Zhou M; Wu X; Liu X; Liu J; Wu Y; Liu D
Herz; 2018 Nov; 43(7):642-648. PubMed ID: 28835968
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations of the paraoxonase gene in patients with coronary artery disease.
Hong SH; Song J; Min WK; Kim JQ
Clin Biochem; 2001 Sep; 34(6):475-81. PubMed ID: 11676977
[TBL] [Abstract][Full Text] [Related]
15. Smoking-dependent and haplotype-specific effects of endothelial nitric oxide synthase gene polymorphisms on angiographically assessed coronary artery disease in Caucasian- and African-Brazilians.
Rios DL; D'Onofrio LO; Souza JK; Queiroz AM; Raduy-Maron L; Silva-Neto N; Carvalho HG; Santos-Filho A; Galvão-Castro B
Atherosclerosis; 2007 Jul; 193(1):135-41. PubMed ID: 16842798
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 beta and interleukin-6 gene polymorphism associations with angiographically assessed coronary artery disease in Brazilians.
Rios DL; Cerqueira CC; Bonfim-Silva R; Araújo LJ; Pereira JF; Gadelha SR; Barbosa AA
Cytokine; 2010 Jun; 50(3):292-6. PubMed ID: 20206549
[TBL] [Abstract][Full Text] [Related]
17. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
[TBL] [Abstract][Full Text] [Related]
18. The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease.
Mohamed RH; Mohamed RH; Karam RA; Abd El-Aziz TA
Clin Biochem; 2010 Apr; 43(6):553-8. PubMed ID: 20026099
[TBL] [Abstract][Full Text] [Related]
19. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M
Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis.
Gupta N; Singh S; Maturu VN; Sharma YP; Gill KD
PLoS One; 2011; 6(5):e17805. PubMed ID: 21629682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
